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Abstract
Background: Genital granulomas induced by Schistosoma haematobium eggs can manifest as different lesion types visible
by colposcopy; rubbery papules (RP), homogenous sandy patches (HSP) and grainy sandy patches (GSP). Pronounced tissue
eosinophilia is a candidate marker for active S. haematobium pathology, as viable schistosome egg granulomas often are
eosinophil rich. Here it was investigated whether eosinophil granule proteins ECP (eosinophil cationic protein) and EPX
(eosinophil protein-X) in urine and genital lavage can be used as markers for active FGS lesions.
Methods: Uro-genital samples from 118 Malagasy women were analysed for ECP and EPX by standard sandwich avidin/
biotin amplified ELISA.
Principal findings: The women with RP lesions had significantly higher levels of ECP and EPX in both lavage and urine.
Furthermore, women with RP lesions were significantly younger than those with GSP. This could indicate that RP lesions
might be more recently established and thus represent an earlier inflammatory lesion stage.
Conclusion: ECP in genital lavage might be a future tool aiding the identification of FGS pathology at a stage where
reversibility remains a possibility following praziquantel treatment.
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Introduction
The poverty associated disease uro-genital schistosomiasis
caused by Schistosoma haematobium affects millions of people in the
Sub-Saharan region resulting in a substantial morbidity burden
ranging from subtle to severe in individuals [1]. The main burden
of morbidity ascribed to uro-genital schistosomiasis is not caused
by the blood-dwelling mature flukes, but rather by the eggs they
release inducing immune-related tissue reactions [2]. Presence of
Schistosoma haematobium eggs not only in the urinary tract but also
the genital tract tissues is far from a new finding, as it was first
described in Egypt in 1899 [3]. Later several post-mortem studies
have demonstrated that eggs occur just as frequently in genital
tissues as in the urinary bladder, however possibly at a lower density
[4–7]. Recently, a number of population-based epidemiological
studies investigating genital manifestations of schistosomiasis in
women, known as female genital schistosomiasis (FGS), have
been carried out in various Sub-Saharan regions. These studies
have demonstrated prevalence of FGS as high as 50% in S.
haematobium endemic areas [8]. Research on various aspects of
FGS has gained momentum as attention has been brought to
hallmark features of the disease, namely disruption of the genital
mucosal barrier, and local vascular and immunological changes.
These factors might exacerbate the risk of contracting sexually
transmitted diseases – of which HIV stands out as the most
prominent consequence [9–11].
Approximately 112 million people are estimated to be infected
with S. haematobium in the Sub-Saharan region of which a large
proportion is at risk of having genital morbidity [12,13]. FGS was
added to the WHO gender task force in 1997 [14,15]. Yet,
assessments of the actual magnitude of FGS are easily prone to
gross underestimations due to insufficient documentation and
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knowledge about the epidemiology and associated morbidity. This
is underlined by the fact, that even if a woman is diagnosed by
state-of-the-art colposcopy, FGS may be overlooked as eggs can be
deposited in un-investigated sites further up in the genital tract or
obscured by the anatomy in the fornices or on the vaginal walls
[5,6,16]. Furthermore, women positive for FGS do not necessarily
excrete eggs in urine enhancing the likelihood of underestimation
of prevalence in areas where knowledge about FGS related
morbidity is limited [17]. Colposcopy reveals visibly different FGS
pathology: rubbery papules (RP), homogenous sandy patches
(HSP), and grainy sandy patches (GSP) [10].
It has been well documented in studies focusing on the urinary
tract that the S. haematobium egg induced granulomas are
dominated by eosinophils [1,18–20], hence tissue eosinophilia is
a candidate marker for inflammatory activity in the genital lesions.
The ability of eosinophils to kill helminths is ascribed to an array of
basic cationic ‘‘attack’’ proteins packed in characteristic granules
and amongst them are eosinophil protein-X (EPX, also known as
eosinophil derived neurotoxin (EDN)) and eosinophil cationic
protein (ECP) [21,22]. The stability and constitutive presence of
these proteins in eosinophils render them attractive candidates as
measures of the degree of tissue eosinophilia, and thus potentially
the inflammatory activity or severity associated with FGS lesions.
It has previously been demonstrated that EPX and in particular
ECP can be used as markers for bladder morbidity in urinary
schistosomiasis [23–25]. Furthermore, earlier studies examining
ECP in genital lavage have indicated a relation between elevated
levels of this granule protein marker and FGS pathology, however
the specific lesion type was not taken into account [26,27]. This
study aimed to investigate the potential of ECP and/or EPX as
candidate markers for distinct FGS lesion pathology in the lower
genital tract.
Materials and Methods
Study area and participants
A FGS case definition study was carried out in June–July 2010
in Miandrivazo district, Madagascar headed by the Institut
Pasteur de Madagascar (IPM). The study participants were
recruited from five villages in Miandrivazo district, which is
located in the western part of Madagascar. Four of the chosen
villages were identified as potential hyper-endemic villages (.50%
S. haematobium prevalence) in previous surveys conducted in 2009
by IPM in collaboration with the schistosomiasis unit at the
Madagascar Ministry of Health. These surveys showed a S.
haematobium eggs in urine prevalence of 82% (61/74) in one village
and 84% (89/106) based on pooled data from two high endemic
villages. In the last high endemic village the prevalence of S.
haematobium was based on observation of a high prevalence of
macro-haematuria as reported by the local medical officer. The
fifth selected village had low S. haematobium endemicity (,20%
prevalence) based on an IPM survey from 1999 which found 8%
(8/96) S. haematobium egg positive in urine. All five villages had
comparable socio-economic levels and infrastructures. Inclusion
criteria for study enrolment were 15–35 years of age, female
gender, not having received anti-schistosomal treatment within the
previous two years and having lived in the district for more than
five years. Exclusion criteria were pregnancy, virginity, and eggs in
urine status. One hundred and eighteen women, who wanted to
participate and met the inclusion criteria, were recruited. Samples
were obtained from 79 women from the four hyper-endemic
villages (all egg positive). The control group consisted of samples
from 39 women from the low endemic village matched by age to
the women from the S. haematobium high endemic villages. Only
control group individuals who did not shed eggs in the collected
urine samples were recruited.
Urine and genital lavage samples
Midstream urine samples were collected between 9am and 2pm
on three consecutive days one of which coincided with the pelvic
exam. A subsample of 10 ml urine was filtrated through a
Nucleopore membrane immediately after collection and subse-
quently counted by standard light microscopy in the field
laboratory. S. haematobium arithmetic mean egg counts (eggs/
10 ml urine) were calculated based on the three urine samples.
The urine sample for ECP and EPX level was collected on the day
of the pelvic examination. An aliquot of 2 ml urine was
immediately snap-frozen in liquid nitrogen. Urine samples were
kept at 280uC and transported to the laboratory on dry ice.
Furthermore, genital lavage was collected by spraying 10 ml 0.9%
NaCl on the cervix and the inner half of the vaginal surfaces,
whereafter it was pulled back into the syringe and re-sprayed. This
was repeated four times in total. A set of 2 ml vials for ECP and
EPX level determination were frozen and kept at 280uC from
collection to the laboratory.
Pelvic exam and STI assessment
As briefly outlined, FGS was diagnosed by colposcopy as
previously described by Kjetland et.al. [10,28] and lesions
categorised as rubbery papules (RP), homogenous sandy patches
(HSP), and grainy sandy patches (GSP). Women presenting with at
least one of either lesion type were considered FGS positive.
Vaginal swabs were taken in order to test for a range of genital
infections. The diagnostic methods used to supplement the clinical
findings for diagnosis are given in brackets; Trichomonas vaginalis
(microscopy of wet-mount and Pap-stained slides, PCR), Neisseria
gonorrhoea (PCR), Chlamydia trachomatis (PCR), Mycoplasma genitalium
(PCR), Human papilloma virus (High-risk-HPV PCR), Candida
albicans (wet-mount microscopy, Pap-stained slides) and bacterial
vaginosis (microscopy of wet-mount (Amsel’s criteria) and Pap-
stained slides). If a genital ulcer was found a swab was applied on
the ulcer to test for Herpes simplex virus type 2 (PCR), and
Haemophilus ducreyi (PCR). Furthermore cytobrush and spatula were
used to collect material for Papanicolaou-stained slides in order to
check for S. haematobium eggs and inflammatory signs. Lastly a
serum sample was also tested for Treponema pallidum (RPR, TPHA).
Author Summary
The blood-dwelling fluke Schistosoma haematobium pro-
duce eggs which can inflict lesions both in the urinary and
genital tract. Lesions in the female genital tract have been
hypothesised to confer higher risk of contraction of HIV
and other genital infections. These epithelial genital
lesions are visibly different and three types can be
observed; rubbery papules, homologous sandy patches
and grainy sandy patches. Like other helminths, active S.
haematobium infection is associated with eosinophilia.
Therefore eosinophil granule proteins might be useful
markers for active inflammation related to female genital
schistosomiasis lesions. This study identifies the rubbery
papules as a potential early-stage inflammatory lesion type
associated with high levels of eosinophil granule proteins
in vaginal lavage. It may be advantageous to identify
female genital lesions relatively early after infection as
chronic inflammation stage lesions might not respond to
praziquantel treatment.
Eosinophil Proteins as FGS Lesion Markers
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Enzyme-linked immunosorbent assay (ELISA)
Urine and genital lavage samples were analysed for ECP and
EPX level in 2012 by standard avidin/biotin amplified sandwich
ELISA using the protocol developed by Claus Reimert [29,30]
with minor alterations in the form of antibody and sample
concentration adjustments. The antibodies used were the same as
utilised by Reimert et. al. Standard curve detection range was 31–
2000 pg/ml for EPX and 16–1000 pg/ml for ECP. Plates were
read at 492 nm with a reference reading at 595 nm in ELISA-
reader (Thermo Scientific Multiskan FC).
Ethical considerations
Ethical permission was granted by the Committee of Ethics at
the Ministry of Health in Madagascar (Nu 031-CE/MINSAN 4
June 2010). A female physician informed the study participants in
the local Malagasy language about the purpose and overview of
the study, the procedures, the benefits and possible negative
consequences of participation, privacy and confidentiality proce-
dures, and the right to ask questions and to withdraw at any time
point. The woman was asked for a signature if she accepted to
participate in the study. Illiterate women who gave their free
consent were asked to stamp their fingerprint. This was a
procedure approved by the Committee of Ethics.
All women diagnosed with schistosomiasis were treated with a
single dose of praziquantel (40 mg/kg body weight). If symptoms
or signs of sexually transmitted infections or other diseases were
observed, treatment or referral in accordance with the standard
syndromic approach used in Madagascar was applied free of
charge. Asymptomatic STIs were treated upon reception of STI
testing results from the laboratory. Partner treatment was offered
by a male doctor in a neighbouring location. All study participant
information was anonymised and securely stored.
Data analysis
ELISA absorbance readings and protein concentration calcu-
lations were handled using SkanIt3.1.0.4 software. Only standard
curves with a correlation co-efficient (r) of minimum 0.95 were
accepted, and protein concentrations were determined using linear
regression. Data were analysed using SPSS 19.0.0 for Windows
(IBM SPSS Inc.), and the graphical representation in figure 1 was
made using GraphPad Prism 4.03 software. Spearman’s correla-
tion co-efficient was used to describe the relation between granule
proteins and mean egg counts. Two-tailed non-parametric Mann-
Whitney U (2-sample) and Kruskall-Wallis (k-sample) tests were
used to test for significant differences in protein levels in
independent samples. In order to test independent variables for
significance, multinominal logistic regression models using pathol-
ogy categories as dependent variable were run (protein levels were
normally distributed after log transformation). Table 1 shows the
lesion category classification used for data analysis.
Accession numbers
UniProtKB/Swiss-Prot
ECP: P12724
EPX: P10153
Results
Women from the hyper-endemic villages (n = 79) had S.
haematobium egg counts in the range from 1–2463 eggs/10 ml
urine with an geometric mean intensity of 35 eggs/10 ml urine
and a median of 51 eggs/10 ml urine. Gynaecological examina-
tions showed that 41 of the total 118 women were FGS positive
(34.7%), whereas 77 had neither a rubbery papule (RP),
homogenous sandy patch (HSP), nor a grainy sandy patch (GSP)
on the vaginal or cervical mucosal surface visible by colposcopy as
described in Kjetland et.al. 2005. Women from the low endemic
village (n = 39) were recruited based on being S. haematobium egg
negative in urine, however, 10 women (25.6%) from this group
were found FGS positive (table 1). No urine egg negative women
had RPs. The FGS prevalence in women from the high endemic
villages was 39.2%. Mean urine egg count was significantly lower
(p = 0.04) in FGS positive compared to FGS negative (FGS
negative egg negative excluded, cat.5). No significant difference in
mean urine egg count was found when comparing the RP group
with the GSP group (p = 0.054). However, HSP positive women
had significantly less eggs in urine compared to RP positive (p,
0.001) and GSP positive (p = 0.007).
The age span of the 118 women was from 15 to 35 years of age
and there was no significant difference in age between FGS
positives and negatives (p = 0.719). However, women with only
GSP lesions were significantly older than RP positive women
(p = 0.007).
Eosinophil cationic protein (ECP)
FGS positive women had a median level of 72.5 ng/ml (range
2.79–5480 ng/ml) of ECP in genital lavage. This significantly
(p = 0.002) exceeded the ECP level found in genital lavage in the
FGS negative women of 24.4 ng/ml (range 0.06–625 ng/ml). In
urine FGS positive women had a median ECP level of 56.1 ng/ml
(range 0.03–1.2712 ng/ml), which was also higher than the level in
FGS negative women of 6.4 ng/ml ECP (range 0.01–1720 ng/
ml). However, this difference was not significant (p = 0.056).
Positive correlations were found between the mean S. haematobium
egg count in urine and the levels of ECP in both genital lavage and
urine (p,0.01). However, the correlation was weaker in genital
lavage (r = 0.257) as compared to urine (r = 0.773).
Eosinophil protein X (EPX)
The median level of EPX in genital lavage was 63.5 ng/ml
(range 0.92–3950 ng/ml) in FGS positive women, which was
significantly (p = 0.003) higher, than the median level found in the
FGS negative group of 10.6 ng/ml for EPX (range 0.12–810 ng/
ml). In urine from FGS positive women the median level of EPX
was 1650 ng/ml (range 103–25400 ng/ml). FGS negative women
had a median level of 875 ng/ml (range 40–8840 ng/ml) in the
urine, which was significantly lower compared to the FGS positive
women (p = 0.024). EPX levels in both genital lavage and urine
were positively correlated to the mean S. haematobium egg count in
urine (p,0.01), but the strongest correlation was found in urine
(r = 0.550) compared to genital lavage (r = 0.403).
Elevated ECP and EPX in women with rubbery papule
lesions
In order to investigate whether the significantly elevated ECP
and EPX levels found in women with FGS were associated with a
particular type of lesion pathology, analysis was done stratified by
lesion categories (table 1). A significant difference between
pathology categories was found for both median ECP (lavage
p,0.001 and urine p = 0.001) and EPX (lavage p,0.001 and
urine p,0.001) levels. Significantly higher levels of ECP found was
found in genital lavage and urine in RP positive women compared
to HSP positives, GSP positives and FGS negative egg negative
women as shown in Figure 1a and 1b. However, the ECP level in
RPs was only significantly higher in genital lavage and not in urine
when comparing to the FGS negative egg positive group (p00.08).
Almost the same pattern applied to EPX where the protein
Eosinophil Proteins as FGS Lesion Markers
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concentration also was significantly higher in genital lavage and
urine in individuals with RP pathology compared to HSP
positives, GSP positives and both categories of FGS negative
women (Figure 1c and 1d).
Multinominal logistic regression show that having RP pathology
encompasses a three-fold risk of elevated ECP (OR = 3.1; 95%
CI[1.7–5.5]) and EPX (OR = 3.4; 95% CI[1.8–6.1]) levels in
genital lavage. The regression analysis was controlled for presence
of other genital infections (Trichomonas vaginalis, Mycoplasma
genitalium, Chlamydia trachomatis, Neisseria gonorrhoea, bacterial vagi-
nosis, Candida albicans or high-risk Human papilloma virus) and
age. Test for Haemophilus ducreyi and Herpes simplex virus type 2
were only carried out if a genital ulcer was suspected (n = 3, no
positives), hence these variables could not be taken into account.
Discussion
The central question here was whether the eosinophil granule
proteins ECP and/or EPX are suitable as identifiers for
inflammatory FGS lesions. The results from this study showed
an elevated level of EPX and ECP in genital lavage in association
with the rubbery papule (RP) type lesion. In contrast sandy
patches (grainy or homogeneous) were not associated with
significantly higher granule protein levels in genital lavage. This
could indicate that RPs represent eosinophil rich lesions, whereas
GSPs and maybe HSPs might represent a later stage of the disease
or at least a different lesion type in terms of inflammation. This
corresponds with previous findings showing that high ECP levels
in lavage were associated with FGS [27] and that ECP levels
Figure 1. Dot plot illustrating the amount (ng/ml) of ECP in genital lavage (a) and in urine (b) and of EPX in genital lavage (c)) and
urine (d) classified by pathology category 1–5 (see table 1). The plus and minus following ‘‘NoFGS’’ in group 4 and 5 refer to the S.
haematobium egg status. The median is indicated with a horizontal bar and interquartile ranges shown. Only significant p values are shown on the
graphs. For ECP in urine two extreme outlies were excluded (b). Note that the ordinate axis is on logarithmic scale.
doi:10.1371/journal.pntd.0002974.g001
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decreased in response to praziquantel treatment [26] although
none of these studies took lesion type into consideration.
The likelihood of contracting schistosomiasis depends on water
contact. Infection intensity measured by urinary egg output
normally peaks in 10–14 year olds where after it declines in
adults depending on the level of transmission [31]. The
observation, that women with GSPs were significantly older than
those with RPs, could hence reflect a difference in lesion type
based on younger women harbouring active infections with higher
infection intensities rather than different age-dependent pathology
patterns. Furthermore, the tendency of higher urine egg count in
RP positive women compared to GSP positive strengthen this
viewpoint. These observations support that the GSP lesion
represent a later stage lesion with calcified eggs and less marked
inflammation. Comparable lesions have been described in the
urinary bladder [1,32,33]. A study of Zimbabwean women from
20 to 49 years of age, who did not portray RPs at all, showed no
resolution of GSP and HSP despite repeated praziquantel
treatment [34] indicating a chronic type lesion pathology. If
different lesions in fact reflect a difference in time of egg deposition
rather than lesions with different inflammatory profiles per se, it is
very likely that reversibility after treatment is only possible in early-
stage inflammatory lesions. Regression of pathology after prazi-
quantel treatment has been shown in several ultrasound based
studies of the urinary tract as well as an interim report indicating a
varying treatment effect on sandy patches in the genital tract [35–
39]. However, it remains to be investigated whether RPs respond
to treatment. It would be very relevant to determine whether
ECP/EPX levels decrease after praziquantel treatment depending
on pathology type.
If RPs are in fact early-stage lesions, it is very likely that they
contain viable S. haematobium eggs, which excrete antigen. Presence
of antigen may spark local immune reactions resulting in activated
endothelial cells and chemotactic recruitment of a range of
immune cells. In vitro studies have demonstrated that soluble egg
antigens (SEA) from S. mansoni eggs induce endothelial cell
proliferation and activation and it is possible that viable S.
haematobium eggs in a similar manner induce vascular activity
[40,41]. Characteristic for S. haematobium granulomas containing
viable eggs is the recruitment of high eosinophil numbers, but also
enhanced macrophage, fibroblast and endothelial cell activity has
been demonstrated [42–44]. As RPs possibly contain viable eggs
which release antigen, they might show similar tissue activity as
lesions described previously. This is indicated in a study of cervico-
vaginal biopsies from Malawian women which found a positive
association between viable parasite ova and granulation tissue rich
in sprouting blood vessels as compared to normal healthy tissue
and to tissue containing calcified ova [44]. A recent case report of
a genital inflammatory lesion which may resemble rubbery papule
was found to contain viable S. haematobium eggs [45].
Some caution is necessary when interpreting ECP/EPX levels
as measures for tissue eosinophilia related to S. haematobium egg
induced RP pathology, since basophils and particularly neutro-
phils occasionally might present a bias as source of the granule
proteins [46–49]. This is especially relevant if strong bacterial co-
infection or allergic responses are present [50,51]. Furthermore,
research is needed in order to establish whether some genital tract
mucosal immune responses dominated by neutrophils might show
significant levels of ECP and EPX, although it is generally
established that eosinophils and not neutrophils are associated with
helminth infections [52–54].
Both ECP and EPX protein levels were higher in association
with RPs in genital lavage, but ECP in appears to be the better
candidate marker, since EPX levels were higher in urine than in
genital lavage even in the control group. Likewise, previous reports
on urine samples from Kenyan children point towards ECP being
superior to EPX as eosinophil marker protein for S. haematobium
infection [24]. Here this observation is expanded to include genital
lavage samples.
Studies conducted in Egypt, Ghana, Madagascar, Malawi,
South Africa and Zimbabwe point towards a significant and
under-recognised FGS related morbidity which may manifest as
diversely as pelvic pain, infertility, a 3-fold increased risk of HIV as
well as various social consequences [55–59]. FGS often present
with symptoms, which are generally difficult to quantify and
obtain accurate information about, such as vaginal discharge,
mucosal contact bleeding, dyspareunia, pelvic pain and genital
itch [28,56,60,61]. Further complicating the diagnostic picture is
an overlap of symptoms which are common in STDs [10,62].
There is thus a need for non-invasive diagnostic research tools for
investigating the epidemiology of FGS and efficacy of treatment
particularly in young women. This study identifies ECP in genital
lavage as a marker for a potential early-stage inflammatory FGS
pathology. Combining this measure with testing for presence of
Table 1. FGS diagnostic categories used for data analysis.
Category: 1 (RP) 2 (HSP) 3 (GSP) 4 (NoFGS eggpos) 5 (NoFGS eggneg)
Rubbery papule (RP) ! - - - -
Homogenous sandy patch (HSP) ? ! - - -
Grainy sandy patch (GSP) ? ? ! - -
Urine egg positive (n) 15 2 14 48 0
Urine egg negative (n) 0 8 2 0 29
Total n 15 10 16 48 29
Mean (median) age 19 (19) 23 (22) 25 (24) 22 (20) 23 (21)
Age range (yrs) 15–25 15–35 16–32 15–33 15–35
Mean (median) egg count 262 (125) 15 (0) 134 (9) 346 (35) 0 (0)
Egg count range 2–1091 0–74 0–877 1–2463 0
!: At least one manifestation of the pathology type in question.
?: The pathology can be present.
- : No manifestations of the given type.
Below the category number in brackets are the terms used in the text and on figure 1 for each grouping.
doi:10.1371/journal.pntd.0002974.t001
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eggs or current infection by schistosome PCR [63] or circulating
anodic antigen (CAA) [64,65] would further improve the
diagnostic potential. This research tool-set could be used to
expand our knowledge of the FGS prevalence and pathogenesis
but most importantly aid in identifying pathology at a stage, where
reversibility remains a possibility. Furthermore, it can shed light on
the role of eosinophils in tissue inflammation in uro-genital
schistosomiasis.
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